Scarica l'app Stockscreener
11.27
5.61%
-0.67
Dopo l'orario di chiusura:
11.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché MED Giù?
Forum
Previsione
Storia dei dividendi
Medifast Inc Borsa (MED) Ultime notizie
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - AD HOC NEWS
Medifast Inc Stock (US58470S1024): valuation in focus after steep multi-year slide - AD HOC NEWS
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management - GlobeNewswire
Medifast (MED) down 5.1% since last earnings report: Can it rebound? - MSN
MED News | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast chief legal officer Jason Groves resigns; company begins search for successor By Investing.com - Investing.com South Africa
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Medifast (NYSE: MED) director awarded 11,680 restricted stock units in fee grant - Stock Titan
Cash-settled RSU grant boosts Medifast (MED) director derivative holdings - Stock Titan
Medifast Inc (NYSE: MED) director Jeffrey Rose files routine Form 3 - Stock Titan
Medifast (NYSE: MED) director details 657,590 indirect shares - Stock Titan
What is Zacks Research's Forecast for Medifast Q2 Earnings? - MarketBeat
Medifast Appoints Nicholas Johnson as New CEO and Amends 2012 Share Incentive Plan - Minichart
Medifast Names Nicholas Johnson as CEO - Moomoo
Medifast Taps Johnson to Succeed Chard as CEO - Moomoo
Medifast names Nicholas Johnson as CEO effective June 1 By Investing.com - Investing.com South Africa
Nicholas Johnson becomes Medifast (NYSE: MED) CEO as investors back equity plan - Stock Titan
Medifast, Inc. Approves Board Elections - marketscreener.com
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Medifast confirms appointment of Nicholas Johnson as chief executive officer - marketscreener.com
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer - Business Wire
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026 - MSN
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - Sahm
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - GlobeNewswire Inc.
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes - Sahm
MEDIFAST INC (MED) Surges +1.12%, Nearing $13.22 Resistance 2026-05-19Call Spread Alert - thelegaladvocate.com
Citadel reports 6.5% stake in MEDIFAST (MED) in joint Schedule 13G - Stock Titan
MED | Medifast, Inc. FinancialsIncome Statement - Quiver Quantitative
Charles Schwab (MED) reports 631,539 shares, 5.74% stake (03/31/2026) - Stock Titan
Renaissance Holdings amends Schedule 13G: 773,710 shares in MED (MED) - Stock Titan
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast director Scott Schlackman buys $62,950 in company stock By Investing.com - Investing.com Nigeria
Medifast director Scott Schlackman buys $62,950 in company stock - Investing.com
Medifast (MED) director Scott Schlackman adds 5,000 shares in open-market buys - Stock Titan
TradingKey - TradingKey
Medifast: Worth Putting On A Watchlist (NYSE:MED) - Seeking Alpha
MED Technical Analysis | Trend, Signals & Chart Patterns | MEDIFAST INC (NYSE:MED) - ChartMill
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan - MSN
Document - SEC.gov
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - The Globe and Mail
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):